==== Front Postgrad Med J Postgrad Med J pmj Postgraduate Medical Journal 0032-5473 1469-0756 Oxford University Press 32727887 postgradmedj-2020-137901 10.1136/postgradmedj-2020-137901 Images AcademicSubjects/MED00160 AcademicSubjects/MED00790 AcademicSubjects/MED00530 Heterogeneity of clinical and radiological findings of COVID-19 https://orcid.org/0000-0002-3807-7287 D’Arena Giovanni Hematology Service, S. Luca Hospital, Vallo Della Lucania (SA), Vallo Della Lucania, Italy Penna Augusto La Radiology, S. Luca Hospital, Vallo Della Lucania (SA), Vallo Della Lucania, Italy Crocamo Antonino Infectious Disease, S. Luca Hospital, Vallo Della Lucania, Italy Sguazzo Francesca Emergency, S. Luca Hospital, Vallo Della Lucania, Italy Viceconti Roberto Infectious Disease, S. Luca Hospital, Vallo Della Lucania, Italy Barlotti Vincenzo Infectious Disease, S. Luca Hospital, Vallo Della Lucania, Italy Gambardella Michele Infectious Disease, S. Luca Hospital, Vallo Della Lucania, Italy Correspondence to Giovanni D’Arena, Hematology Service, ‘S. Luca’ Hospital, ASL Salerno, Vallo Della Lucania, Italy; giovannidarena@libero.it 4 2021 29 7 2020 29 7 2020 97 1146 268269 14 4 2020 01 6 2020 22 4 2020 © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2021 https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com ==== Body pmcThe pandemic COVID-19 caused by the 2019 novel coronavirus called severe acute respiratory syndrome coronavirus-2 displays a very heterogeneous clinical behaviour. The majority of patients (>85%) are asymptomatic or have mild symptoms, while few others show a very aggressive and life-threatening disease. Imaging spectrum of COVID-19 is very heterogenous as well: from normal picture in patients with mild symptoms such as fever and dry cough (figures 1 and 2) to pneumonia with multiple patchy, peripheral, bilateral areas of ground-glass opacity (GGO) and consolidation as in more severe illness (figures 3–8). A quick evolution of the disease is also seen. Involvement of both lungs seems to be the main imaging feature (75–100% of cases)1  2 usually with GGOs (77–91%)1  3 and consolidations (55–69%)1  3 in peripheral regions. Pleural effusions may occur in a minority of cases (4.1% of cases vs 39% in non-COVID-19 viral pneumonia)1; lymphadenopathy is rare, and pulmonary nodules and cavitation are not described.1, 2, 3 These imaging characteristics must be taken into account because they may help clinicians to better diagnose COVID-19 especially in an early phase4 and differentiate it from other viral cases of pneumonia (central distribution of lesions was observed in 80% vs 57% of cases in non-COVID-19 viral pneumonia in one study)1 or bacterial infections (usually with lobar or segmental consolidation).5 Figure 1 Thin slice (1 mm) lung CT of patients. Figure 2 Singular intralobular GGO of a 31-year-old male patient with fever and cough. GGO, ground-glass opacity. Figure 3 Bilateral patchy subpleural GGOs and small peripheral consolidation of a 56-year-old female with fever, cough and dyspnoea. GGO, ground-glass opacity. Figure 4 CT at presentation of a 62-year-old female with fever, cough and dyspnoea: perifissural GGOs in posterior segment of right upper lobe and small bilateral pleural effusion. GGO, ground-glass opacity. Figure 5 Follow-up at day 5: increased size and density of previous lesions, onset of new multiple bilateral GGOs and consolidations in both subpleural and central localisation, with interlobular septal thickening, and increased pleural effusion. GGO, ground-glass opacity Figure 6 Follow-up at day 19: partial regression of the lesions with residual smaller GGOs, irregular parenchymal bands and interlobular septal thickening; reduction of bilateral pleural effusion with residual pleural fissure thickening and/or distortion. GGO, ground-glass opacity. Figure 7 CT of a 38-year-old female with fever, cough, dyspnoea and anosmia at presentation: subpleural/peripheral GGOs. GGO, ground-glass opacity. Figure 8 CT at day 9: increasing size and density of previous lesions, onset of new irregular consolidations with parenchymal bands and architectural distortion. Footnotes Contributors: GDA, AC, FS, RV, VB, MG followed patients and wrote the paper. AL performed diagnostic imaging. All authors reviewed and approved the manuscript. Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Competing interests: None declared. Patient consent for publication: Not required. Provenance and peer review: Not commissioned; internally peer reviewed. ==== Refs REFERENCES 1 Bai  HX, Hsieh  B, Xiong  Z, et al.  Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology  2020.10.1148/radiol.2020200823 2 Wang  D, Hu  B, Hu  C, et al.  Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA  2020.10.1001/jama.2020.1585 3 Song  F, Shi  N, Shan  F, et al.  Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology  2020;295 :210–7.10.1148/radiol.2020200274 32027573 4 Zu  ZY, Jiang  MD, Xu  PP, et al.  Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology  2020;21 :200490.10.1148/radiol.2020200490 5 Simpson  S, Kay  FU, Abbara  S, et al.  Radiological Society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. J Thorac Imaging  2020;21 .10.1097/RTI.0000000000000524